COLOSAFE

COLOSAFE is a brand of gastrointestinal medications developed and marketed by Jointcare Pharmaceuticals, primarily featuring rabeprazole sodium as the active ingredient. The core product, COLOSAFE-20, is a 20 mg oral tablet formulation of rabeprazole, a proton pump inhibitor (PPI) that works by irreversibly inhibiting the H+/K+ ATPase enzyme system (the gastric acid pump) in the parietal cells of the stomach. This action reduces gastric acid secretion, making it effective for treating acid-related conditions such as gastroesophageal reflux disease (GERD), peptic ulcer disease, Zollinger-Ellison syndrome, and hyperacidity. The brand family also includes combination products like COLOSAFE-DSR, which adds domperidone for prokinetic effects, and COLOSAFE-L, which includes levosulpiride for conditions like irritable bowel syndrome.

Brand names

COLOSAFECOLOSAFE-20COLOSAFE20COLOSAFE 20COLOSAFE-DSRCOLOSAFE-L

Other names

rabeprazole sodium